Malagón, JairVillaveces, MarianaManent, Lluis2017-11-052025-08-052017-11-052025-08-052017-11-050121-2133https://repositorio.juanncorpas.edu.co/handle/001/388Introduction: Fibromyalgia is a condition that affects up to 5% of the population and causes significant deterioration of the quality of life for the sufferer, so it is a therapeutic challenge. The objective of the present study was to describe the experience of the AtlasPROfilax® method in patients with fibromyalgia diagnosed according to the criteria of the American College of Reumatology (ACR) 2010.Methodology: A cross - sectional study with 63 patients with fibromyalgia was done. Patients were monitored two and six months after applying the AtlasPROfilax® method, in order to evaluate the pain level by visual analogue scale VAS and reevaluate ACR criteria in the follow-up appointment.Results: The average age of patients was 48.5 SD 12.6 years, 95.24% were female. 100% of patients improved pain (initial VAS of 8 vs 4 and 3 after two and six months respectively) and these were significant results. A reduction of widespread pain index as well as a reduction in the presence of symptoms such as fatigue, non-restorative sleep and cognitive disorders that are typical of fibromyalgia were also found in 46% of casesConclusion: This study has provided evidence of the effectiveness of the neuromuscular stimulation method of the suboccipital musculature called AtlasPROfilax® in the treatment of fibromyalgia. Randomized and controlled studies are required to demonstrate the medium and long term effectiveness of this therapeutic alternative.application/pdfengJAIR MALAGON, MARIANA VILLAVECES, LLUIS MANENT - 2017https://creativecommons.org/licenses/by-nc-sa/4.0/fibromyalgiapainmanagementmedicineFibromyalgiaCausalgiaCombined Modality TherapyArtículo de revista10.26752/cuarzo.v23.n1.2212500-7181https://doi.org/10.26752/cuarzo.v23.n1.221info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2